Probi signs agreement with a probiotic leader in India

Probi signs agreement with a probiotic leader in India

Probi has signed a distribution agreement with USV Limited, a leading Indian
Pharmaceutical company. USV will launch Vibact IBS based on the probiotic
formulation Probi Digestis, in Q4 2012 in the growing Indian market. The
agreement reinforces and strengthens Probi's existing presence in the large
Indian market.

“USV is the best probiotic partner in the consumer healthcare sector in India.
We are very pleased to partner with USV and to be able to launch our probiotic
formulation Probi Digestis in a market with significant growth potential”, says
Michael Oredsson, CEO of Probi.

Probi’s capsules based on the Lactobacillus plantarum 299v strain will be
launched under the Vibact IBS brand and will feature Probi´s logo and ingredient
prominently on the pack. USV offers a market leading probiotic prescription
brand, Vibact, in India. Vibact IBS will specifically target IBS symptoms like
bloating, flatulence and pain. These are symptoms which are common in the Indian
population. USV will use its extensive field force to market the product across
India.

“Probi’s well-documented and effective IBS probiotic will be a unique addition
to our range and will strengthen our market position. We are certain that the
product will be well received in the market,” says Mr. Prashant Tewari, Managing
Director at USV.

Probi’s partner Institut Rosell’s current distribution agreements in India
covering Lp299v capsules with Aristo Pharmaceuticals and Ranbaxy will remain in
force but limited overlap is expected.

The information is such that Probi AB must disclose in accordance with the
Swedish Securities Market Act and/or the Financial Instruments Trading Act.

FOR FURTHER INFORMATION, CONTACT:

Michael Oredsson, CEO, Probi, phone. +46 46 286 89 23 or mobile +46 707 18 89 30

e-mail: michael.oredsson@probi.se

Niklas Bjärum, Vice President Marketing & Sales, Probi, phone. +46 46 286 89 67
or

mobile: +46 705 38 88 64, e-mail: niklas.bjarum@probi.se